neurostar, tms therapy, repetitive transcranial magnetic stimulation, transcranial magnetic stimulation, rtms, tms, depression treatments, depression, depression clinical research, depression clinical trials, depression research trials, neuronetics, ect, electroconvulsive therapy, vns, vagus nerve stimulation, investors, bruce shook, president & ceo, mark bausinger, mark demitrack, md, chief medical officer, peter anastasiou, vp marketing, mark riehl, vp product development & operations, stanford miller, vp health policy and access, judy ways, ph.d., vp ra/qa, resistant depression, antidepressant, antidepressants, clinical depression, sadness, low mood

tms therapy is a safe and effective treatment for depression. neuronetics specializes in the clinical delivery of this treatment through its neurostar tms therapy system.